483 Anthony J. Olszanski, M.D., RPh Jul 2019

483 Anthony J. Olszanski, M.D., RPh Jul 2019

Stephanie Mangigian FDA, Anastasia Offordile FDA, Anastasia Onuorah FDA$119.00 - Available Now

FDA investigators audited the Anthony J. Olszanski, M.D., RPh - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 25 Jul 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jul 2019
  • Location: Philadelphia, United States
  • FEI: 3015340041
Add To Cart